iHuman Inc. Files 2025 Annual Report on Form 20-F

Rhea-AI Summary

iHuman (NYSE: IH) filed its 2025 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission on April 24, 2026 for the year ended December 31, 2025.

The Form 20-F is available on the company's investor relations website and a free hard copy of the annual report containing audited financial statements is available to shareholders and ADS holders upon request at the listed Beijing address.

News Market Reaction – IH

+1.88%

1 alert

+1.88% Session close to close

$84.33M Market Cap

0.1x Rel. Volume

In the Apr 27 session, IH gained 1.88%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement confirms that iHuman filed its audited 2025 annual report on Form 20-F with the SE...

Analysis

This announcement confirms that iHuman filed its audited 2025 annual report on Form 20-F with the SEC, making detailed financials and risk disclosures available to investors. It follows earlier unaudited FY2025 results and dividend announcements, formalizing those figures. Investors reviewing the filing may focus on trends already highlighted in prior updates, regulatory and structural risks, and any commentary on the operating environment as context for future earnings and capital return decisions.

Key Figures

Form type: Form 20-F Fiscal year end: December 31, 2025 Filing date: April 24, 2026 +3 more

6 metrics

Form type Form 20-F Annual report filing for year ended December 31, 2025

Fiscal year end December 31, 2025 Year covered by the filed Form 20-F

Filing date April 24, 2026 Date Form 20-F was filed with SEC

Tower number Tower 306 Corporate mailing address for report requests

Street number No. 86 Street address in Chaoyang District for report requests

Postal code 100101 Beijing postal code in the company’s mailing address

Historical Context

3 past events · Latest: Mar 31 (Neutral)

Pattern 3 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 31	Earnings release	Neutral	+1.5%	Unaudited Q4 and FY2025 results with revenue decline but continued profitability and dividend.
Dec 29	Earnings release	Neutral	-0.9%	Q3 2025 results showing revenue decline, solid margins and strong cash position.
Nov 24	Conference appearance	Neutral	-2.4%	Announcement of company presentation at NobleCon21 investor conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent earnings and corporate updates have led to relatively modest single-day price moves, suggesting measured reactions to news.

Recent Company History

Over the past several months, iHuman has focused on financial reporting and investor outreach. Unaudited Q4 and FY2025 results on Mar 31, 2026 showed lower revenue but continued profitability and a special cash dividend, with shares up 1.49%. Q3 2025 results on Dec 29, 2025 similarly reported revenue declines but ongoing profitability and strong cash, with a -0.91% move. A NobleCon21 conference appearance on Nov 24, 2025 coincided with a -2.37% reaction. Today’s Form 20-F filing formalizes previously disclosed FY2025 figures.

Key Terms

form 20-f, securities and exchange commission, ads

3 terms

form 20-f regulatory

"announced that it filed its annual report on Form 20-F for the year ended"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

securities and exchange commission regulatory

"with the U.S. Securities and Exchange Commission on April 24, 2026."

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

ads financial

"to its shareholders and ADS holders upon request."

Ads are paid promotional messages a company places across media — online, on TV, in print, or on social platforms — to attract customers, explain products, or shape public perception. For investors, ads matter because they drive sales growth, affect how much a company must spend to win customers, and influence brand strength and long-term value. Ads can also create regulatory or reputational risk if claims are misleading, which can affect profits and stock price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEIJING, April 24, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 24, 2026. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements for the year ended December 31, 2025, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to iHuman Inc., Tower 306, No. 86 Beiyuan Road, Chaoyang District, Beijing 100101, People's Republic of China.

About iHuman Inc.

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit https://ir.ihuman.com/.

For investor and media enquiries, please contact:

iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86-10-5780-6606
E-mail: ir@ihuman.com

Christensen
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: ihumangroup@christensencomms.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-files-2025-annual-report-on-form-20-f-302753327.html

SOURCE iHuman Inc.

FAQ

When did iHuman (IH) file its 2025 Form 20-F with the SEC?

iHuman filed its 2025 Form 20-F on April 24, 2026. According to iHuman, the filing covers the fiscal year ended December 31, 2025 and is available on the company's investor relations website for review.

Where can investors access iHuman's (IH) 2025 annual report and audited financial statements?

Investors can access the 2025 Form 20-F on iHuman's investor relations website. According to iHuman, a free hard copy with complete audited financial statements is available upon request to shareholders and ADS holders.

How can shareholders request a hard copy of iHuman's (IH) 2025 annual report?

Shareholders and ADS holders can request a free hard copy by contacting iHuman at the Beijing address provided. According to iHuman, requests should be directed to the listed office address in Chaoyang District, Beijing.

Does the iHuman (IH) Form 20-F include audited financial statements for 2025?

Yes. According to iHuman, the annual report on Form 20-F contains complete audited financial statements for the year ended December 31, 2025 and will be provided free of charge to eligible requestors.

Will iHuman (IH) provide the 2025 Form 20-F in physical and online formats?

Yes. According to iHuman, the Form 20-F is available online via the investor relations website and a printed hard copy with audited financials is available free to shareholders and ADS holders upon request.